1. Home
  2. ACXP vs SSM Comparison

ACXP vs SSM Comparison

Compare ACXP & SSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.38

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Logo Sono Group N.V. Ordinary Shares

SSM

Sono Group N.V. Ordinary Shares

HOLD

Current Price

$1.06

Market Cap

6.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACXP
SSM
Founded
2017
2016
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
6.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ACXP
SSM
Price
$1.38
$1.06
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $95.50
N/A
AVG Volume (30 Days)
77.2K
★ 2.3M
Earning Date
05-12-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1,462,987.20
Revenue Next Year
N/A
$48.49
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$1.09
52 Week High
$8.34
$10.54

Technical Indicators

Market Signals
Indicator
ACXP
SSM
Relative Strength Index (RSI) 43.46 29.72
Support Level $1.33 N/A
Resistance Level $1.46 $4.50
Average True Range (ATR) 0.05 0.38
MACD -0.00 -0.10
Stochastic Oscillator 35.48 0.44

Price Performance

Historical Comparison
ACXP
SSM

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About SSM Sono Group N.V. Ordinary Shares

Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and services include Complete Solar Solutions, Solar Charge Controllers, Solar Modules, Data Services, and Engineering Services. The company's single business segment manages the financing, research and development, and product commercialization.

Share on Social Networks: